IFNL3 and viral infectious disease: Low baseline ISG expression in the liver of patients with HCV is beneficial as it provides a basis for a potent antiviral response in the context of IFN-α based therapy69, but this may not be the case for other viral infections controlled by IFN-λ3, and requires further study7, 9.